Published in J Biol Chem on August 04, 2017
Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis. Front Immunol (2017) 0.75
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput (2008) 34.90
Protein production by auto-induction in high density shaking cultures. Protein Expr Purif (2005) 29.74
Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A Gen Phys (1985) 26.82
Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins (2006) 22.80
Predominant autoantibody production by early human B cell precursors. Science (2003) 13.14
The atomic structure of protein-protein recognition sites. J Mol Biol (1999) 12.63
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science (1985) 10.42
Anatomy of hot spots in protein interfaces. J Mol Biol (1998) 9.70
Interfaces and the driving force of hydrophobic assembly. Nature (2005) 8.54
A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem (2004) 8.13
Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol (1997) 6.88
Isolating and engineering human antibodies using yeast surface display. Nat Protoc (2006) 5.02
Dissecting protein-protein recognition sites. Proteins (2002) 4.51
Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat Protoc (2006) 3.48
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc (1988) 3.07
Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol (2007) 2.92
Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol (2011) 2.41
Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol (2003) 2.35
Optimizing protein stability in vivo. Mol Cell (2009) 2.15
Van der waals picture of liquids, solids, and phase transformations. Science (1983) 1.71
A de novo protein binding pair by computational design and directed evolution. Mol Cell (2011) 1.65
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J Mol Biol (2008) 1.64
Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol (2004) 1.56
Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci (2006) 1.55
Characterizing hydrophobicity of interfaces by using cavity formation, solute binding, and water correlations. Proc Natl Acad Sci U S A (2009) 1.54
X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. J Mol Biol (1993) 1.52
Selection for improved protein stability by phage display. J Mol Biol (1999) 1.46
Computer-aided antibody design. Protein Eng Des Sel (2012) 1.44
The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol (2008) 1.41
Fluctuations of water near extended hydrophobic and hydrophilic surfaces. J Phys Chem B (2010) 1.36
Instantaneous liquid interfaces. J Phys Chem B (2010) 1.35
Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains. J Biol Chem (2007) 1.26
Selection of horseradish peroxidase variants with enhanced enantioselectivity by yeast surface display. Chem Biol (2007) 1.23
Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation. Proc Natl Acad Sci U S A (2013) 1.21
Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies. MAbs (2009) 1.20
Extended surfaces modulate hydrophobic interactions of neighboring solutes. Proc Natl Acad Sci U S A (2011) 1.14
Idiotypic selection of an antibody mutant with changed hapten binding specificity, resulting from a point mutation in position 50 of the heavy chain. EMBO J (1986) 1.12
The functional capacity of the natural amino acids for molecular recognition. Mol Biosyst (2010) 1.12
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool. Protein Eng Des Sel (2013) 1.11
Thermodynamically stable aggregation-resistant antibody domains through directed evolution. J Mol Biol (2007) 1.09
Rapid method for measuring ScFv thermal stability by yeast surface display. Biotechnol Prog (2003) 1.09
Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries. J Mol Biol (2003) 1.08
High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site. Proc Natl Acad Sci U S A (1993) 1.06
Highly avid magnetic bead capture: an efficient selection method for de novo protein engineering utilizing yeast surface display. Biotechnol Prog (2009) 1.05
Structure-based design of conformation- and sequence-specific antibodies against amyloid β. Proc Natl Acad Sci U S A (2011) 1.05
Redesigning an antibody fragment for faster association with its antigen. Biochemistry (2003) 1.04
Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. J Mol Biol (2004) 1.03
Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key. PLoS One (2007) 1.02
An improved coarse-grained model of solvation and the hydrophobic effect. J Chem Phys (2011) 1.02
Amino acid preferences at protein binding sites. FEBS Lett (1994) 1.02
Modulation of hydrophobic interactions by proximally immobilized ions. Nature (2015) 0.99
The CamSol method of rational design of protein mutants with enhanced solubility. J Mol Biol (2014) 0.94
Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions. J Mol Biol (2010) 0.94
Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. J Mol Biol (2002) 0.93
The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Arthritis Res Ther (2004) 0.92
Mutational analysis of 48G7 reveals that somatic hypermutation affects both antibody stability and binding affinity. J Am Chem Soc (2013) 0.91
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. Proc Natl Acad Sci U S A (2016) 0.90
Efficient method to characterize the context-dependent hydrophobicity of proteins. J Phys Chem B (2014) 0.88
Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome. Arthritis Rheum (2007) 0.88
Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions. J Immunol Methods (2004) 0.88
Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency. Proc Natl Acad Sci U S A (2013) 0.86
Large-scale analysis of somatic hypermutations in antibodies reveals which structural regions, positions and amino acids are modified to improve affinity. FEBS J (2013) 0.85
Antibody library screens using detergent-solubilized mammalian cell lysates as antigen sources. Protein Eng Des Sel (2010) 0.84
Cells and cell lysates: a direct approach for engineering antibodies against membrane proteins using yeast surface display. Methods (2012) 0.84
Non-repetitive single-chain Fv linkers selected by selectively infective phage (SIP) technology. Protein Eng (1998) 0.83
Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources. Protein Eng Des Sel (2012) 0.82
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigen. Mol Immunol (2004) 0.82
Inhibition of aggregation of amyloid β42 by arginine-containing small compounds. Biosci Biotechnol Biochem (2012) 0.82
Complementary combining site contact residue mutations of the anti-digoxin Fab 26-10 permit high affinity wild-type binding. J Biol Chem (2002) 0.81
Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies. Protein Eng Des Sel (2015) 0.80
Selection of peptide inhibitors of soluble Aβ(1-42) oligomer formation by phage display. Biosci Biotechnol Biochem (2010) 0.80
Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process. Protein Eng Des Sel (2015) 0.79
Antibody light chain variable domains and their biophysically improved versions for human immunotherapy. MAbs (2014) 0.77
Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide. J Biol Chem (2015) 0.76
Physical chemistry: Hydrophobic interactions in context. Nature (2015) 0.75
Identification of novel short peptide inhibitors of soluble 37/48 kDa oligomers of amyloid β42. Biosci Biotechnol Biochem (2011) 0.75
Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability. Sci Rep (2017) 0.75